Cloud-based healthcare tools provider Inovalon, which is headquartered in the US, has acquired compatriot VigiLanz, a company specialising in clinical surveillance and data.  

Financial details of this transaction were not divulged. 

Founded in 2001, VigiLanz is a provider of software-as-a-service-based clinical surveillance and patient safety technology.  

The company primarily aims to advance clinical surveillance and data connectivity as well as patient safety software solutions to support hospitals, clinical facilities and life sciences companies in delivering quality healthcare while minimising potential harm. 

VigiLanz also serves as a clinical partner to a vast network of hospital control specialists, safety teams, pharmacists and other healthcare professionals by providing real-time inpatient and outpatient care. 

Through VigiLanz’s acquisition, Inovalon aims to strengthen its provider and life sciences solution portfolios while also expanding its customer base and clinical data connectivity.  

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The merger is expected to speed up Inovalon’s growth in data-enabled healthcare solutions, promoting greater clinical surveillance and safety. 

It will also help reduce adverse outcomes, improve patient safety, and reduce overall healthcare expenses, stated the company. 

In addition, the integration of VigiLanz into Inovalon’s operations is anticipated to increase Inovalon’s addressable market prospects by over $340m in its provider market offering and over $5.7bn in life sciences market offerings. 

Inovalon founder and CEO Keith Dunleavy said: “VigiLanz has created an impressively high-quality organisation with the industry leadership of its software and strength of its customer relationships matched only perhaps by its positive culture and relentless attention to mission. 

“We are excited to bring together VigiLanz’s subject matter expertise and leading clinical safety and surveillance software offering with Inovalon’s broad data resources, analytical toolsets, and large installed customer base of nearly 20,000 healthcare organisations to empower greater outcomes and economics across the healthcare ecosystem.” 

Inovalon provides Cloud-based software solutions that empower data-driven healthcare. It has developed “ONE Platform”, which combines national-scale connectivity, real-time primary source data access, and analytics into one cloud-based platform.